4Indexed trials
drug · Product Intelligence
Haloperidol
Pipeline Intelligence
Haloperidol: 4 indexed trials, 3 sponsors; 0 linked Orange Book patents and 12 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
12FDA-linked events
Development evidence
NCT01185418Chonbuk National University Hospital · schizophreniaCOMPLETED
NCT03628391Erasmus Medical Center · schizophreniaPHASE3
NCT03743649M.D. Anderson Cancer Center · other_psychiatryPHASE2, PHASE3
NCT05431595M.D. Anderson Cancer Center · epilepsyPHASE2, PHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALHALOPERIDOL DECANOATE · 2025-05-13
FDA_APPROVALHALOPERIDOL · 2024-04-19
FDA_APPROVALHALOPERIDOL DECANOATE · 2023-05-23
FDA_APPROVALHALOPERIDOL · 2023-01-17
FDA_APPROVALHALOPERIDOL DECANOATE · 2017-05-12
FDA_APPROVALHALOPERIDOL · 2004-08-25
FDA_APPROVALHALOPERIDOL DECANOATE · 1998-01-30
FDA_APPROVALHALOPERIDOL · 1988-06-03
FDA_APPROVALHALOPERIDOL · 1988-06-03
FDA_APPROVALHALOPERIDOL · 1988-06-03
FDA_APPROVALHALOPERIDOL · 1987-08-25
FDA_APPROVALHALOPERIDOL · 1986-04-11
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.